Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.2 |
mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.17 | 0.2 |
mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.2 |